DK0949258T3 - Alfa-liponsyre i krystallinsk form - Google Patents

Alfa-liponsyre i krystallinsk form

Info

Publication number
DK0949258T3
DK0949258T3 DK99104155T DK99104155T DK0949258T3 DK 0949258 T3 DK0949258 T3 DK 0949258T3 DK 99104155 T DK99104155 T DK 99104155T DK 99104155 T DK99104155 T DK 99104155T DK 0949258 T3 DK0949258 T3 DK 0949258T3
Authority
DK
Denmark
Prior art keywords
alpha
crystalline form
lipoic acid
enantiomer
theta
Prior art date
Application number
DK99104155T
Other languages
Danish (da)
English (en)
Inventor
Thomas Dr Beisswenger
Eberhard Oestreich
Karl-Friedrich Dr Landgraf
Gunter Dr Laban
Matthias Dr Rischer
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Application granted granted Critical
Publication of DK0949258T3 publication Critical patent/DK0949258T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Seasonings (AREA)
DK99104155T 1998-03-11 1999-03-02 Alfa-liponsyre i krystallinsk form DK0949258T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19810336A DE19810336A1 (de) 1998-03-11 1998-03-11 Alpha-Liponsäure mit neuartiger Modifikation
US09/074,645 US5994393A (en) 1998-03-11 1998-05-08 Alpha-lipoic acid with novel modification

Publications (1)

Publication Number Publication Date
DK0949258T3 true DK0949258T3 (da) 2002-01-28

Family

ID=26044524

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99104155T DK0949258T3 (da) 1998-03-11 1999-03-02 Alfa-liponsyre i krystallinsk form

Country Status (10)

Country Link
US (1) US5994393A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0949258B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE207914T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2265276C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY1106435T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE19810336A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0949258T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2164474T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN186598B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT949258E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834608A1 (de) * 1998-07-31 2000-02-03 Basf Ag Kristallmodifikation der Liponsäure
JP2003535115A (ja) * 2000-06-06 2003-11-25 ビーエーエスエフ アクチェンゲゼルシャフト 化粧品及び外皮用剤におけるリポ酸の（ｒ）−鏡像異性体の使用
DE10151764A1 (de) * 2001-10-19 2003-05-08 Basf Ag Kombination von Liponsäure und Glutamin in Lebens- und Arzneimitteln
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
CN104055764A (zh) * 2004-11-24 2014-09-24 希尔氏宠物营养品公司 改进动物异生素物质肝清除率的方法
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
EP1830629A4 (en) 2004-12-30 2008-08-27 Hills Pet Nutrition Inc METHODS FOR ENHANCING THE QUALITY OF LIFE OF AN ANIMAL AGE
EP2389178A4 (en) * 2008-12-01 2012-06-06 Invasc Therapeutic Inc COMPOSITIONS CONTAINING INHIBITORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND LIPOIC ACID COMPOUNDS, AND THEIR USE FOR THE TREATMENT OF RENIN-ANGIOTENSIN-ALDOSTERONE ASSOCIATED DISORDERS
CN108484570B (zh) * 2018-05-15 2021-05-04 苏州富士莱医药股份有限公司 一种制备硫辛酸颗粒的方法及设备

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0812590A3 (de) * 1989-11-09 1999-06-09 ASTA Medica Aktiengesellschaft Verwendung von R-Alpha-Liponsäure zur Zytoprotektion
DE4218572A1 (de) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E
DE4235912C2 (de) * 1992-10-23 2002-12-05 Viatris Gmbh Verfahren zur Herstellung kristalliner Thioctsäure und deren Verwendung
DE4433764A1 (de) * 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit

Also Published As

Publication number Publication date
DE19810336A1 (de) 1999-09-23
CA2265276A1 (en) 1999-09-11
EP0949258B1 (de) 2001-10-31
CY1106435T1 (el) 2011-04-06
ES2164474T3 (es) 2002-02-16
EP0949258A1 (de) 1999-10-13
IN186598B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2001-10-06
ATE207914T1 (de) 2001-11-15
US5994393A (en) 1999-11-30
PT949258E (pt) 2002-04-29
DE59900364D1 (de) 2001-12-06
CA2265276C (en) 2009-09-08

Similar Documents

Publication Publication Date Title
GR3033191T3 (en) Dosage form comprising alpha-lipoic acid or solid salts thereof with improved bioavailability
CA2349227A1 (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
AU589155B2 (en) Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido) azabicycloalkanes
CA2331395A1 (en) Fatty acid analogues for the treatment of diabetes
EP1004578A3 (en) 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
WO2003051846A3 (de) Substituierte phenylderivate
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
EP0031567A3 (en) Tetrapeptidesemicarbazide derivatives and their production and use
DK0949258T3 (da) Alfa-liponsyre i krystallinsk form
NZ279397A (en) Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives and pharmaceutucal compositions
WO2004028482A3 (en) Packaged personal care compositions
IL140826A0 (en) Crystal modification of lipoic acid
CA2333008A1 (en) New heterocyclically substituted amides, their production and their use
WO2001014493A3 (de) Anorganische beschichtungszusammensetzung, ein verfahren zu deren herstellung sowie deren verwendung
GB8320203D0 (en) Anti-viral compositions
SI0843967T1 (en) Use of Beta-aminopropionic acid derivatives as fungicides
ZA200207675B (en) Novel crystal form of pyrrolidylthiocarbapenem derivative.
BR0107743B1 (pt) processo para manufatura de grade positiva fina para baterias de chumbo ácidas e grade.
CA2180533A1 (en) Process for producing aromatic or heteroaromatic sulfur compounds
EP1398306A3 (en) A (1'R, 2'S, 5'R)-3-l-Menthoxyalkan-1-ol cooling sensate
TW200512337A (en) Carrier band material and carrier band
IE45109L (en) N-2-imidazolidinylidene-benzeneamine
EP1692952A3 (en) Flavouring a foodstuff with compounds containing a sulphur atom linked to two specific atoms or groups
IE840085L (en) 2-iminopyrrolidine derivatives
TW200502235A (en) Novel benzo[1,2,5]thiadiazoles and pharmaceutical use thereof